Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment

Biomaterials

Volumn 32, Issue 11, 2011, Pages 2907-2917

  Peng, Chun Wei ^a   Liu, Xiu Li ^a   Chen, Chuang ^a   Liu, Xiong ^a   Yang, Xue Qin ^a   Pang, Dai Wen ^b   Zhu, Xiao Bo ^c   Li, Yan ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c Wuhan Jiayuan Quantum Dots Co Ltd   (China)

Author keywords

Cancer invasion; Multiplexed imaging; Nanomedicine; Quantum dots; Tumor microenvironment

Indexed keywords

CANCER INVASION; MULTIPLEXED IMAGING; NANOMEDICINE; QUANTUM DOTS; TUMOR MICROENVIRONMENT;

DISEASES; ENZYME ACTIVITY; MEDICAL NANOTECHNOLOGY; MULTIPLEXING; SEMICONDUCTOR QUANTUM DOTS; SPECTRUM ANALYSIS; TECHNOLOGY;

TUMORS;

COLLAGEN TYPE 4; GELATINASE B; QUANTUM DOT;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; PRIORITY JOURNAL; SPECTROSCOPY; STOMACH CANCER; STROMA; TUMOR MICROENVIRONMENT;

BREAST NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; QUANTUM DOTS; STOMACH NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 79951577786     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.053     Document Type: Article

References (40)

1. Wolf K., Wu Y.I., Liu Y., Geiger J., Tam E., Overall C., et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007, 9(8):893-904.
2. Xu R., Boudreau A., Bissell M.J. Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer Metastasis Rev 2009, 28(1-2):167-176.
3. Albini A., Sporn M.B. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007, 7(2):139-147.
4. Rowe R.G., Weiss S.J. Navigating ECM barriers at the invasive front: the cancer cell-stroma interface. Annu Rev Cell Dev Biol 2009, 25:567-595.
5. Polyak K., Haviv I., Campbell I.G. Co-evolution of tumor cells and their microenvironment. Trends Genet 2009, 25(1):30-38.
6. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003, 3(6):422-433.
7. Johann D.J., Rodriguez-Canales J., Mukherjee S., Prieto D.A., Hanson J.C., Emmert-Buck M., et al. Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry. J Proteome Res 2009, 8(5):2310-2318.
8. Heppner G.H., Miller B.E. Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Rev 1983, 2(1):5-23.
9. Liu J., Lau S.K., Varma V.A., Moffitt R.A., Caldwell M., Liu T., et al. Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano 2010, 4(5):2755-2765.
10. Pelley J.L., Daar A.S., Saner M.A. State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol Sci 2009, 112(2):276-296.
11. Resch-Genger U., Grabolle M., Cavaliere-Jaricot S., Nitschke R., Nann T. Quantum dots versus organic dyes as fluorescent labels. Nat Methods 2008, 5(9):763-775.
12. Chen L.D., Liu J., Yu X.F., He M., Pei X.F., Tang Z.Y., et al. The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis. Biomaterials 2008, 29(31):4170-4176.
13. Gokarna A., Jin L.H., Hwang J.S., Cho Y.H., Lim Y.T., Chung B.H., et al. Quantum dot-based protein micro- and nanoarrays for detection of prostate cancer biomarkers. Proteomics 2008, 8(9):1809-1818.
14. Chen C., Peng J., Xia H.S., Yang G.F., Wu Q.S., Chen L.D., et al. Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials 2009, 30(15):2912-2918.
15. Chen C., Xia H.S., Gong Y.P., Peng J., Peng C.W., Hu M.B., et al. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials 2010, 31(33):8818-8825.
16. Ben-Ari E.T. Nanoscale quantum dots hold promise for cancer applications. J Natl Cancer Inst 2003, 95(7):502-504.
17. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307(5709):538-544.
18. Polyak K., Kalluri R. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol 2010, 10.1101/cshperspect.a003244.
19. Friedl P., Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2010, 188(1):11-19.
20. Friedl P., Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009, 10(7):445-457.
21. Friedl P., Maaser K., Klein C.E., Niggemann B., Krohne G., Zanker K.S. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res 1997, 57(10):2061-2070.
22. Friedl P., Wolf K. Tube travel: the role of proteases in individual and collective a cancer cell invasion. Cancer Res 2008, 68(18):7247-7249.
23. Hu M., Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008, 18(1):27-34.
24. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9(4):239-252.
25. Peng C.W., Liu X.L., Liu X., Li Y. Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. J Transl Med 2010, 8(1):101.
26. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298(5599):1759-1762.
27. Wu X., Liu H., Liu J., Haley K.N., Treadway J.A., Larson J.P., et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003, 21(1):41-46.
28. Coussens L.M., Fingleton B., Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002, 295(5564):2387-2392.
29. Hotary K.B., Allen E.D., Brooks P.C., Datta N.S., Long M.W., Weiss S.J. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003, 114(1):33-45.
30. Ingber D.E. Can cancer be reversed by engineering the tumor microenvironment?. Semin Cancer Biol 2008, 18(5):356-364.
31. Mammoto A., Huang S., Moore K., Oh P., Ingber D.E. Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27kip1 pathway and the G1/S transition. J Biol Chem 2004, 279(25):26323-26330.
32. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8(3):241-254.
33. Folkman J. Angiogenesis. Annu Rev Med 2006, 57:1-18.
34. Kerbel R.S. Molecular origins of cancer: tumor angiogenesis. N Engl J Med 2008, 358(19):2039-2049.
35. Kleinman M.E., Yamada K., Takeda A., Chandrasekaran V., Nozaki M., Baffi J.Z., et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 2008, 452(7187):591-597.
36. Sudhakar A., Sugimoto H., Yang C.Q., Lively J., Zeisberg M., Kalluri R. Human tumstatin land human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci U S A 2003, 100(8):4766-4771.
37. Mundel T.M., Yliniemi A.M., Maeshima Y., Sugimoto H., Kieran M., Kalluri R. Type IV collagen alpha 6 chain-derived noncollagenous domain 1 (alpha 6(IV)NC1) inhibits angiogenesis and tumor growth. Int J Cancer 2008, 122(8):1738-1744.
38. Coffelt S.B., Hughes R., Lewis C.E. Tumor-associated macrophages: effectors of angiogenesis and tumor progression. BBA Rev Cancer 2009, 1796(1):11-18.
39. Luo Y.P., Zhou H., Krueger J., Kaplan C., Lee S.H., Dolman C., et al. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 2006, 116(8):2132-2141.
40. Sierra J.R., Corso S., Caione L., Cepero V., Conrotto P., Cignetti A., et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med 2008, 205(7):1673-1685.